BioCorRx (BioCorRx) EBIT per Share : $-0.35 (TTM As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is BioCorRx EBIT per Share?

BioCorRx's EBIT per Share for the three months ended in Dec. 2023 was $-0.08. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.35.

During the past 3 years, the average EBIT per Share Growth Rate was 15.80% per year. During the past 5 years, the average EBIT per Share Growth Rate was 27.90% per year. During the past 10 years, the average EBIT per Share Growth Rate was 15.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for BioCorRx's EBIT per Share or its related term are showing as below:

BICX' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -779.4 Med: 0.3 Max: 31.7
Current: 15.8

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of BioCorRx was 31.70% per year. The lowest was -779.40% per year. And the median was 0.30% per year.

BICX's 3-Year EBIT Growth Rate is ranked better than
59.64% of 498 companies
in the Healthcare Providers & Services industry
Industry Median: 7.75 vs BICX: 15.80

BioCorRx's EBIT for the three months ended in Dec. 2023 was $-0.68 Mil.

BioCorRx EBIT per Share Historical Data

The historical data trend for BioCorRx's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioCorRx EBIT per Share Chart

BioCorRx Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

-1.26

-0.56

-0.72

-0.46

-0.35

BioCorRx Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EBIT per Share	Get a 7-Day Free Trial															-0.13	-0.11	-0.09	-0.08	-0.08

BioCorRx EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

BioCorRx's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-2.884	/	8.344
=	-0.35

BioCorRx's EBIT per Share for the quarter that ended in Dec. 2023 is calculated as

	EBIT per Share		(Q: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-0.675	/	8.624
=	-0.08

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.35

BioCorRx (OTCPK:BICX) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

BioCorRx EBIT per Share Related Terms

Thank you for viewing the detailed overview of BioCorRx's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

BioCorRx (BioCorRx) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » BioCorRx Inc (OTCPK:BICX) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

2390 East Orangewood Avenue, Suite 500, Anaheim, CA, USA, 92806

Website

https://www.biocorrx.com

BioCorRx Inc through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders. The BioCorRx Recovery Program is a non-addictive, medication-assisted treatment program for substance abuse that includes peer recovery support. The UnCraveRx Weight Loss Management Program is a medically assisted weight management program that is combined with a virtual platform application.

Executives

Louis C. Lucido	director	2390 EAST ORANGEWOOD AVENUE, SUITE 500, ANAHEIM CA 92806
Joseph J Galligan	director, 10 percent owner	333 SOUTH GRAND AVENUE, 18TH FLOOR, LOS ANGELES CA 90071
Harsha Murthy	director	5209 38TH STREET,NW, WASHINGTON DC 20015
Luisa Ingargiola	director	4826 BLUE JAY CIRCLE, PALM HARBOR FL 34683
Thomas Patrick Welch	officer: Vice President of Operations	10453 SARAH ST., TOLUCA LAKE CA 91602
Kent Emry	director, officer: Chief Executive Officer	2390 EAST ORANGEWOOD AVENUE, SUITE 500, ANAHEIM CA 92806
Brady James Granier	director	13024 DELANO STREET, VALLEY GLEN CA 91401
Lourdes Felix	director, officer: Chief Financial Officer	15 CALLE VERANO, RANCHO SANTA MARGARITA CA 92688
Jorge Jr Andrade	director, officer: Chief Executive Officer	PO BOX 5366, SANTA ANA CA 92704
Muller Neil Terrence Mr	director, officer: President	13231 SANDHURST PLACE, SANTA ANA CA 92705